About 3 results found for searched term "Lenvatinib" (0.105 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1841 | Lenvatinib | VEGFR/PDGFR |
| E7080 | ||
| Lenvatinib (E7080) is a potent inhibitor of multiple tyrosine kinases, including VEGF-R3 tyrosine kinase (IC50=5.2 nM) and VEGF-R2 tyrosine kinase (IC50=4.0 nM). | ||
| M14920 | Lenvatinib mesylate | VEGFR/PDGFR |
| E7080 mesylate | ||
| Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities. | ||
| M56621 | O-Demethyl Lenvatinib | Metabolite/Endogenous Metabolite |
| O-Demethyl Lenvatinib is a metabolite of Lenvatinib. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
